Ally Bridge Group
Focus: Healthtech & bioAlly Bridge Group took part in 2 of the startup funding rounds we tracked in 2026, leading or co-leading 1 worth $315m. By money raised, its biggest sector was Healthtech & bio. The largest was AdvanCell's $315m Series D+ round. The most recent was Galvanize Therapeutics's Series D+ round in November 2026.
Deployed as lead$315m
Rounds led1
Rounds joined2
Largest round$315m